Hôpital de Tenon

Paris 75020

0 studies enrolling now · 2 studies all time

What they study most

Advanced Hepatocellular Carcinoma (HCC), Non-small Cell Lung Cancer

Studies at this site

• A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC — Stopped early
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed